Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · Real-Time Price · USD
2.560
0.00 (0.00%)
At close: Jan 16, 2026, 4:00 PM EST
2.550
-0.010 (-0.39%)
Pre-market: Jan 20, 2026, 7:33 AM EST
BDTX Market Cap
BDTX has a market cap or net worth of $145.86 million as of January 20, 2026. Its market cap has increased by 20.45% in one year.
Market Cap
145.86M
Enterprise Value
30.02M
1-Year Change
20.45%
Ranking
Category
Stock Price
$2.56
Market Cap Chart
Since January 30, 2020, BDTX's market cap has decreased from $1.36B to $145.86M, a decrease of -89.24%. That is a compound annual growth rate of -31.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 145.86M | 5.35% |
| Dec 31, 2025 | 138.45M | 14.33% |
| Dec 31, 2024 | 121.09M | -16.54% |
| Dec 29, 2023 | 145.09M | 121.66% |
| Dec 30, 2022 | 65.46M | -66.10% |
| Dec 31, 2021 | 193.10M | -83.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 30, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |